期刊文献+

比卡鲁胺合成路线图解

Graphical Synthetic Routes of Bicalutamide
原文传递
导出
摘要 比卡鲁胺(bicalutamide,1),化学名为(4-)-N-[4-氰基-3-(三氟甲基)苯基]-3-[(4-氟苯基)磺酰基]-2-羟基.2一甲基丙酰胺,是由英国AstraZeneca公司开发的非甾体雄激素拮抗剂,1995年在英国获准上市,主要用于治疗前列腺癌。研究表明(R).比卡鲁胺(2)的抗雄激素活性是(S).型异构体3的60倍,且肝代谢较慢,有利于减轻肝脏负担。
机构地区 大理学院药学院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第8期713-717,共5页 Chinese Journal of Pharmaceuticals
  • 相关文献

参考文献14

  • 1沈佳其,施振华,宁奇.(R)-比卡鲁胺的合成[J].中国医药工业杂志,2006,37(2):73-75. 被引量:3
  • 2肖涛,张孝清,田春梅,王锦堂.比卡鲁胺的合成[J].合成化学,2003,11(4):346-348. 被引量:3
  • 3Pizzatti E,Vigano E,Lussana M. Procedure for the synthesis of bicalutamide[P].US,20060041161,2006.
  • 4Howard T. Amide derivatives[P].EP,0100172,1984.
  • 5Tucker H,Crook JW,Chesterson GJ. Nonsteroidal antiandrogens.Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides[J].Journal of Medicinal Chemistry,1988.954-959.
  • 6Venkatasubramanian R,Suresh M,Anil P. Process for preparation of bicalutamide[P].WO,2006103689,2006.
  • 7Shintaku T,Katsura T,Itaya N. Crystal of bicalutamide and production method thereof[P].US,6740770,2004.
  • 8Tetsuya S,Tadashi K,Kiyoshi S. Process for producing bicalutamide and method of purifying intermediate therefor[P].EP,1679306,2006.
  • 9Thijs L,Keltjens R,Jan G. Process for making bicalutamide and intermediates thereof[P].US,6818766,2004.
  • 10Béla S,Zoltán T,Gy(o)rgy G. Process for the synthesis of N-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenyl-sulfonyl)-2-hydroxy-2-methyl-propionamide[P].WO,0100608,2001.

二级参考文献10

  • 1Tucker H, Chesterson GJ. Resolution of the nonsteroidal antiandrogen 4'-cyanao-3-[(4-fluorophenyl) sulfonyl] -2-hydroxy-2-methyl-3'~ (trifluoromethyl) propionanilide and the determination of the absolute configuration of the active enantiomer [J]. J Med Chem, 1988, 31 (4): 885-887.
  • 2James KD,Ekwuribe NN.Synthesis of enantiomerically pure(R)-and(S)-bicalutamide[J].Tetrahedron,2002,58(29):5905—5908.
  • 3Kirkovsky L, Mukherjee A, Yin DH, et al. Chiral nonsteroidal affinity ligands for the androgen receptor.1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring[J] .J Med Chem, 2002, 43(4) : 581-590.
  • 4Miller DD, Kirkovsky LI, Dalton JT, et al. Irreversible nonsteroidal antagonist compound and its use in the treatment of prostate cancer[P]. US: 6071957, 2000-06-06. (CA 2000,133: 12739a).
  • 5Richard J.Thurlow. Treatment Options for Benign Prostatic Hyperplasia[J]. Emerging Drugs, 1998, 3 (1) :225- 246.
  • 6Laura Sepp-Lorenzino, Susan Slovin. Prostate Cancer:Therapeutic Patent Review [J ]. Exp. Opin.Ther Patents, 2000,10(12) :1833-1842.
  • 7Ekwuribe Nnochiri N,James Kenneth D. Resolution of Intermediates in the Synthesis of Substantially Pure Bicalutamide[P]. WO 01-34 563 A1,2001.
  • 8Howard Tucker, Crook J W, Chesterson G J, Nonsteroidal Antiandrogens. Synthesis and Structure-Activity Relationships of 3-Substituted Derivatives of 2-Hydroxypropionanilides [J]. J. Med. Chem., 1988, 31:954-959.
  • 9Howard Tucker,Macclesfield. Amide Derivatives[P].4 636 505,1987.
  • 10Winston Ho,Gene F Tutwiler,Sandra C Cottrell,Dava J. Morgans. Alkylglycidic Acidz Potential New Hypoglycemic Agents[J].J. Med. Chem.,1986,29:2184-2190.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部